Publikacje

  1. Buszman PP, Milewski K, Pajak J, Jelonek M, Orlik B, Krauze A, Gwiazdowska-Nowotka B, Wojakowski W, Tellez A, Granada JF, Buszman PE. Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms. EuroIntervention. 2014 Jan 28. pii: 20121101-02.
  2. Buszman PP, Milewski K, Zurakowski A, Pajak J, Jelonek M, Gąsior P, Peppas A, Tellez A, Granada JF, Buszman PE. Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine. Catheter Cardiovasc Interv. 2013 May 23.
  3. Wojakowski W, Pyrlik A, Król M, Buszman P, Ochała A, Milewski K, Smolka G, Kawecki D, Rudnik A, Pawłowski T, Jadczyk T, Wyderka R, Cybulski W, Dworowy S, Tendera M. Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial). Minerva Cardioangiol. 2013 Jun;61(3):301-11.
  4. Kiesz RS, Wiernek SL, Wiernek BK, Radvany MG, Buszman PP, Szymański R, Konkolewska MD, Martin JL, Buszman PE. Long term results of plaque excision combined with aggressive pharmacotherapy in high risk patients with advanced peripheral artery disease (save a leg registry). Catheter Cardiovasc Interv. 2012 Nov 21. doi: 10.1002/ccd.24756
  5. Buszman PP, Orlik B, Trela B, Milewski K, Kozlowski M, Pruski M Jr, Drzewiecki J, Peppas A, Granada JF, Kaluza GL, Buszman PE. Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: Insights from a multicenter, propensity score-matched registry. Catheter Cardiovasc Interv. 2012 Oct 29
  6. Milewski K, Gorycki B, Buszman PP, Jelonek M, Beaudry D, Lapointe JM, Guy LG, Abusamra M, Pająk J, Kinasz W, Wojakowski W, Leclerc G, Gil R, Buszman PE. Vascular Response and Mechanical Integrity of the New Biodegradable Polymer Coated Sirolimus Eluting PROLIM Stent Implanted in Porcine Coronary Arteries. Kardiol Pol. 2012
  7. Wojakowski W, Tendera M, Cybulski W, Zuba-Surma E. K., Szade K, Florczyk U, Kozakowska M, Szymula A, Krzych Ł, Paslawska U, Pasławski R, Milewski K, Buszman P.P, Nabiałek E, Kuczmik W, Janiszewski A, Dzięgiel P, Buszman P.E, Józkowicz A, Dulak J. Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on the reperfusion injury in experimental myocardial infarction. Thromb Haemost. 2012 Sep 4;108(3):464-75.
  8. Buszman PP, Szymanski R, Debinski M, et al. Long-term results of cephalad arteries percutanoeus transluminal angioplasty with stent implantation (The CAPTAS registry). Catheter Cardiovasc Interv;79:532-40.
  9. Buszman PP, Wojakowski W, Milewski K, et al. Controlled Reperfusion with Intravenous Bivalirudin and Intracoronary Abciximab Combination Therapy in the Porcine Myocardial Infarction Model. Thromb Res.
  10. Milewski K, Zurakowski A, Pajak J, et al. Effects of local intracoronary paclitaxel delivery using the Remedy transport catheter on neointimal hyperplasia after stent implantation in a porcine model. Cardiovasc Revasc Med;12:82-9.
  11. Debinski M, Buszman PP, Milewski K, et al. Intracoronary adiponectin at reperfusion reduces infarct size in a porcine myocardial infarction model. Int J Mol Med;27:775-81.
  12. Kiesz RS, Wiernek BK, Wiernek SL, et al. Cardiva Catalyst II vascular access management device in percutaneous diagnostic and interventional procedures with same-day discharge (Catalyst II trial). J Endovasc Ther;18:46-53.
  13. Vassilev D, Gil R, Milewski K. Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model. EuroIntervention;7:614-20
  14. 14. Buszman P, Milewski K, Zurakowski A, Pajak J, Liszka Ł, Buszman P, Musioł E, AbuSamra M, Trznadel S, Kałuza G. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries. Kardiol Pol. 2010 May;68(5):503-9.
  15. Milewski K, Zurakowski A, Pajak J, Pajak-Zielinska E, Liszka L, Buszman PP, Bis J, Debinski M, Buszman PE. Comparison of thin-strut cobalt-chromium stents and stainless steel stents in a porcine model of neointimal hyperplasia. Med Sci Monit. 2010 Jan;16(1):BR40-4.
  16. Buszman PE, Buszman PP, Kiesz RS, Bochenek A, Trela B, Konkolewska M, Wallace-Bradley D, Wilczyński M, Banasiewicz-Szkróbka I, Peszek-Przybyla E, Krol M, Kondys M, Milewski K, Wiernek S, Debiński M, Zurakowski A, Martin JL, Tendera M. Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry. J Am Coll Cardiol. 2009 Oct 13.
  17. Zurakowski A, Wojakowski W, Dzielski T, Milewski K, Gościńska-Bis K, Tendera M, Buszman P. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting. Kardiol Pol. 2009 Jun;67(6):623-30.
  18. Spargias K, Milewski K, Debinski M, Buszman PP, Cokkinos DV, Pogge R, Buszman P. Drug delivery at the aortic valve tissues of healthy domestic pigs with a Paclitaxel-eluting valvuloplasty balloon. J Interv Cardiol. 2009 Jun;22(3):291-8
  19. Buszman PE, Kiesz SR, Bochenek A, Peszek-Przybyla E, Szkrobka I, Debinski M, Bialkowska B, Dudek D, Gruszka A, Zurakowski A, Milewski K, Wilczynski M, Rzeszutko L, Buszman P, Szymszal J, Martin JL, Tendera M. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol. 2008 Feb 5;51(5):538-45
  20. 20. Buszman P, Trznadel S, Milewski K, Rzeźniczak J, Przewłocki T, Kośmider M, Wójcik J, Janczak J, Zurakowski A, Kondys M, Król M, Kinasz L, Jaklik A, Rzeszutko Ł, Kałuza GL, Kiesz S, Gil R. Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: a prospective multicenter registry. Catheter Cardiovasc Interv. 2008 Jan 1;71(1):51-7.
  21. Buszman P, Trznadel S, Zurakowski A, Milewski K, Kinasz L, Król M, Kondys M. Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions. Kardiol Pol. 2007 Sep;65(9):1041-6
  22. Buszman P, Zurakowski A, Gruszka A, Szkróbka I, Peszek-Przybyła E, Radwan K, Milewski K, Barteczko Z, Tendera M. Local paclitaxel delivery as a treatment of persistent, recurrent in-stent restenosis -- safety assessment. Kardiol Pol. 2006 Mar;64(3):268-72
  23. Buszman P, Zurakowski A, Kinasz L, Gorycki B, Król M, Lewicki A, Flak Z, Milewski K, Zurek P. The new Polish stent Chopin. Assessment of safety and efficacy in the treatment of de-novo coronary lesions using percutaneous angioplasty. Kardiol Pol. 2005 May;62(5):451-9